SCHEMBL19127

SCHEMBL19127

C=C1CCC(c2cc(CC)n3nccc3n2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.41
CDK2 P24941 4/20 0.38
CCNA2 P20248 2/20 0.38
CCNA1 P78396 2/20 0.38
CHEK1 O14757 1/20 0.38
CDK9 P50750 10/20 0.36
CDK7 P50613 4/20 0.36
CDK13 Q14004 2/20 0.36
CDK12 Q9NYV4 2/20 0.36
HTR2C P28335 2/20 0.35
HTR2B P41595 2/20 0.35
HTR2A P28223 1/20 0.35
CCNT1 O60563 9/20 0.35
CCNH P51946 3/20 0.35
CDK4 P11802 2/20 0.33
CCND1 P24385 2/20 0.33
CCNK O75909 1/20 0.33
CDK14 O94921 1/20 0.33
CYP1A2 P05177 1/20 0.33
CDK1 P06493 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20974 0.80 CHEK1 (0.59) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL22064 0.72 PDE10A (0.34) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL47770 0.72 PDE10A (0.49) PDE10ACDK2CCNA2CCNA1CDK9
SCHEMBL11608751 0.70 PRKAB2 (0.49) PDE10ACDK2CCNA1CDK9CDK7
SCHEMBL21212195 0.69 PDE10A (0.51) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL14492447 0.68 CDK2 (0.48) PDE10ACDK2CCNE1HTR1DHTR3A
SCHEMBL24965992 0.67 PDE10A (0.38) PDE10ACDK2CDK9CDK7HTR2C
SCHEMBL21212591 0.66 CDK2 (0.46) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL7846641 0.66 CHEK1 (0.68) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL15576805 0.66 GSK3B (0.47) PDE10ACDK2CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027236-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS SCHERING CORPORATION (US) 2012-03-01 WO disclosed